|
1
|
Martin MJ: Current stage-specific
chemotherapeutic options in colon cancer. Expert Rev Anticancer
Ther. 5:695–704. 2005.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Utomo B, Alvarez C and Baldonedo RF:
Management of colorectal cancer patients undergoing a colonic
stenting: A multidisciplinary team approach. Gastroenterol Nurs.
40:342–349. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Willaert W, Mareel M, Van De Putte D, Van
Nieuwenhove Y, Pattyn P and Ceelen W: Lymphatic spread, nodal count
and the extent of lymphadenectomy in cancer of the colon. Cancer
Treat Rev. 40:405–413. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhang Z, Jia H, Wang Y, Du B and Zhong J:
Association of MACC1 expression with lymphatic metastasis in
colorectal cancer: A nested case-control study. PLoS One.
16(e0255489)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ye X, Brabletz T, Kang Y, Longmore GD,
Nieto MA, Stanger BZ, Yang J and Weinberg RA: Upholding a role for
EMT in breast cancer metastasis. Nature. 547:E1–E3. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Iorio J, Duranti C, Lottini T, Lastraioli
E, Bagni G, Becchetti A and Arcangeli A: KV11.1
potassium channel and the Na+/H+ antiporter
NHE1 K pH in colorectal cancer cells. Front Pharmacol.
11(848)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hou X, Tang L, Li X, Xiong F, Mo Y, Jiang
X, Deng X, Peng M, Wu P, Zhao M, et al: Potassium channel protein
KCNK6 promotes breast cancer cell proliferation, invasion, and
migration. Front Cell Dev Biol. 9(616784)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Abbott GW: KCNE4 and KCNE5: K(+) channel
regulation and cardiac arrhythmogenesis. Gene. 593:249–260.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yu H, Lin Z, Mattmann ME, Zou B,
Terrenoire C, Zhang H, Wu M, McManus OB, Kass RS, Lindsley CW, et
al: Dynamic subunit stoichiometry confers a progressive continuum
of pharmacological sensitivity by KCNQ potassium channels. Proc
Natl Acad Sci USA. 110:8732–8737. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Biasiotta A, D'Arcangelo D, Passarelli F,
Nicodemi EM and Facchiano A: Ion channels expression and function
are strongly modified in solid tumors and vascular malformations. J
Transl Med. 14(285)2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wu B, Tao L, Yang D, Li W, Xu H and He Q:
Development of an immune infiltration-related eight-gene prognostic
signature in colorectal cancer microenvironment. Biomed Res Int.
2020(2719739)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Song L, Li XX, Liu XY, Wang Z, Yu Y, Shi
M, Jiang B and He XP: EFEMP2 suppresses the invasion of lung cancer
cells by inhibiting epithelial-mesenchymal transition (EMT) and
down-regulating MMPs. Onco Targets Ther. 13:1375–1396.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang D, Wang S, Chen J, Liu H, Lu J,
Jiang H, Huang A and Chen Y: Fibulin-4 promotes osteosarcoma
invasion and metastasis by inducing epithelial to mesenchymal
transition via the PI3K/Akt/mTOR pathway. Int J Oncol.
50:1513–1530. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chen J, Liu Z, Fang S, Fang R, Liu X, Zhao
Y, Li X, Huang L and Zhang J: Fibulin-4 is associated with tumor
progression and a poor prognosis in ovarian carcinomas. BMC Cancer.
15(91)2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhao J, Xu J, Zhao J and Zhang R: EFEMP2
promotes colon cancer cell invasion and growth through the ERK1/2
signaling pathway. Int J Clin Exp Pathol. 12:851–856.
2019.PubMed/NCBI
|
|
17
|
Yao L, Lao W, Zhang Y, Tang X, Hu X, He C,
Hu X and Xu LX: Identification of EFEMP2 as a serum biomarker for
the early detection of colorectal cancer with lectin affinity
capture assisted secretome analysis of cultured fresh tissues. J
Proteome Res. 11:3281–3294. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Phillips PA, McCarroll JA, Park S, Wu MJ,
Pirola R, Korsten M, Wilson JS and Apte MV: Rat pancreatic stellate
cells secrete matrix metalloproteinases: implications for
extracellular matrix turnover. Gut. 52:275–282. 2003.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Siwy Z, Heins E, Harrell CC, Kohli P and
Martin CR: Conical-nanotube ion-current rectifiers: the role of
surface charge. J Am Chem Soc. 126:10850–10851. 2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shepherd VA, Beilby MJ and Shimmen T:
Mechanosensory ion channels in charophyte cells: the response to
touch and salinity stress. Eur Biophys J. 31:341–355.
2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Van den Eynde C, De Clercq K and Vriens J:
Transient receptor potential channels in the
epithelial-to-mesenchymal transition. Int J Mol Sci.
22(8188)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kärki T and Tojkander S: TRPV Protein
family-from mechanosensing to cancer invasion. Biomolecules.
11(1019)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hu Z, Wei W, Zhou L, Chen M and Abbott GW:
Kcne4 deletion sex-specifically predisposes to cardiac arrhythmia
via testosterone-dependent impairment of RISK/SAFE pathway
induction in aged mice. Sci Rep. 8(8258)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zuo T, Shan J, Liu Y, Xie R, Yu X and Wu
C: EFEMP2 mediates GALNT14-dependent breast cancer cell invasion.
Transl Oncol. 11:346–352. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang L, Chen Q, Chen Z, Tian D, Xu H, Cai
Q, Liu B and Deng G: EFEMP2 is upregulated in gliomas and promotes
glioma cell proliferation and invasion. Int J Clin Exp Pathol.
8:10385–10393. 2015.PubMed/NCBI
|
|
27
|
Yuen HF, McCrudden CM, Huang YH, Tham JM,
Zhang X, Zeng Q, Zhang SD and Hong W: TAZ expression as a
prognostic indicator in colorectal cancer. PLoS One.
8(e54211)2013.PubMed/NCBI View Article : Google Scholar
|
